Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05675306 · ClinicalTrials.gov registry record · NA
Dose Frequency RCT on DTTC in Children With CAS
A NA study of Childhood Apraxia of Speech, sponsored by Marquette University.
- Active
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05675306 is a NA study of Childhood Apraxia of Speech that is active but no longer recruiting, run by Marquette University. The registered enrollment target is 60 participants, below the 177-participant average among 3 other Childhood Apraxia of Speech trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05675306, a NA study of Childhood Apraxia of Speech, is active but no longer recruiting, sponsored by Marquette University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Childhood apraxia of speech (CAS) is a pediatric motor-based speech sound disorder that requires a specialized approach to intervention (Maas et al., 2014). The extant literature on the treatment of CAS commonly recommends intensive treatment using a motor-based approach, with some of the best evidence supporting the use of Dynamic Temporal and Tactile Cueing (DTTC; Strand, 2020). To date, a rigorous and systematic comparison of high and low dose frequency has not been undertaken for DTTC, resulting in a lack of evidence to guide decisions about the optimal treatment schedule for this intervention. The current study aims to fill this gap in knowledge by comparing treatment outcomes when dose frequency is varied. The goal of this clinical trial is to determine whether the number of treatment sessions per week has an effect on intervention outcomes in 60 children with CAS. The main question this research will address is whether whole word accuracy will differ between two groups of children undergoing DTTC treatment when one group of children receives treatment twice a week for 12 weeks and the other group receives treatment 4 times a week for 6 weeks. Community clinicians will administer all treatment sessions.
Conditions Studied
Interventions
- BEHAVIORAL Dynamic Temporal and Tactile Cueing Treatment
Study Locations (1)
Wisconsin
- Marquette U - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05675306
The ClinicalTrials.gov registry entry for NCT05675306 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 177-participant average among 3 other Childhood Apraxia of Speech trials with a reported enrollment target (66% lower). The listed sponsor is Marquette University, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Childhood Apraxia of Speech appearing as the primary indexed condition, and to 1 intervention - of which Dynamic Temporal and Tactile Cueing Treatment is the first listed.
NCT05675306 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05675306 about?
NCT05675306 is a clinical study titled "Dose Frequency RCT on DTTC in Children With CAS". Childhood apraxia of speech (CAS) is a pediatric motor-based speech sound disorder that requires a specialized approach to intervention (Maas et al., 2014). The extant literature on the treatment of CAS commonly recommends intensive treatment using a motor-based approach, with some of the best evide...
What is the current status of trial NCT05675306?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-03-01. Estimated completion is 2025-12-31.
What conditions does trial NCT05675306 study?
This clinical trial studies the following conditions: Childhood Apraxia of Speech.
What interventions are being tested in trial NCT05675306?
The interventions under investigation include: Dynamic Temporal and Tactile Cueing Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT05675306?
This trial is sponsored by Marquette University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05675306 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Childhood Apraxia of Speech
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.